Clinical Trial Update: Inuniv and Working Memory [Phase 4]

View source ↗

Summary

Phase 4 trial update notes completion of a study evaluating Inuniv (guanfacine) and working memory in Attention Deficit Hyperactivity Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Inuniv (guanfacine)

Snippet

Sponsor: Lori A. Schweickert, MD | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED